Northlane Capital Partners has invested in SAI MedPartners, a consultancy firm focused on the pharmaceutical industry.

SAI provides strategy support services to assist clients across the product development lifecycle.

“We are thrilled to partner with NCP, which has an impressive track record of investing in businesses that support the pharmaceutical and medical device industries,” said Erik Nordhoy, CEO of SAI. “NCP’s investment will allow us to further strengthen our client engagement model by providing us with the resources to significantly augment our suite of services and continue to expand globally.”